Aceso Life Science Group Limited (HKG:0474)
Hong Kong · Delayed Price · Currency is HKD 0.1500
-0.0020 (-1.32%)
Sep 11, 2026, 3:58 PM HKT
Aceso Life Science Group Revenue
In the fiscal year ending March 31, 2026, Aceso Life Science Group had annual revenue of -59.00M HKD. Aceso Life Science Group had revenue of -50.00M in the half year ending March 31, 2026.
Revenue
-59.00M
Revenue Growth
n/a
P/S Ratio
-22.52
Revenue / Employee
-2.11M
Employees
28
Market Cap
1.33B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | -59.00M | 80.00M | - |
| Mar 31, 2025 | -139.00M | -150.00M | - |
| Mar 31, 2024 | 11.00M | -196.00M | -94.69% |
| Mar 31, 2023 | 207.00M | 37.00M | 21.76% |
| Mar 31, 2022 | 170.00M | 299.00M | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Horizon Construction Development | 10.43B |
| Chenqi Technology | 8.83B |
| CSSC (Hong Kong) Shipping Company | 3.13B |
| China Aircraft Leasing Group Holdings | 2.78B |
| Progressive Path Group Holdings | 841.32M |
| Dida Inc. | 559.12M |
| Kaisa Capital Investment Holdings | 224.10M |
| AP Rentals Holdings | 144.81M |
Aceso Life Science Group News
- 4 weeks ago - Aceso Life Science Reports FY2026 Profit On Strategic Realignment - Nasdaq